Cargando…

A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China

BACKGROUND: Type 2 diabetes is associated with acute and chronic complications and poses a large economic, social, and medical burden on patients and their families as well as society. OBJECTIVE: This study aims to evaluate the direct economic burden of type 2 diabetes in China. Data source: systema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Huimei, Sawhney, Monika, Shi, Lizheng, Duan, Shengnan, Yu, Yunxian, Wu, Zhihong, Qiu, Guixing, Dong, Hengjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374079/ https://www.ncbi.nlm.nih.gov/pubmed/25652613 http://dx.doi.org/10.1007/s13300-015-0096-0

Ejemplares similares

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2015)

Economic burden of antibiotic resistance in China: a national level estimate for inpatients
por: Zhen, Xuemei, et al.
Publicado: (2021)

Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients
por: Zhen, Xuemei, et al.
Publicado: (2021)

Whether New Cooperative Medical Schemes Reduce the Economic Burden of Chronic Disease in Rural China
por: Jing, Shanshan, et al.
Publicado: (2013)

The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study
por: Li, Yuanyuan, et al.
Publicado: (2022)

Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
por: Zhen, Xuemei, et al.
Publicado: (2019)

Economic burden of adult patients with β-thalassaemia major in mainland China
por: Zhen, Xuemei, et al.
Publicado: (2023)

Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis
por: Gu, Shuyan, et al.
Publicado: (2020)

Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province
por: Zhang, Hao, et al.
Publicado: (2015)

Direct economic burden of patients with autoimmune encephalitis in western China
por: Li, Aiqing, et al.
Publicado: (2020)

A preliminary analysis of the effect of the new rural cooperative medical scheme on inpatient care at a county hospital
por: Ye, Chiyu, et al.
Publicado: (2013)

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2022)

Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
por: Feldman, Steven R., et al.
Publicado: (2015)

Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2022)

Determinants of knowledge translation from health technology assessment to policy-making in China: From the perspective of researchers
por: Liu, Wenbin, et al.
Publicado: (2018)

The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis
por: Zhen, Xuemei, et al.
Publicado: (2019)

Economic and Comorbidity Burden Among Moderate‐to‐Severe Psoriasis Patients with Comorbid Psoriatic Arthritis
por: Feldman, Steven R., et al.
Publicado: (2015)

Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
por: Liu, Wenbin, et al.
Publicado: (2019)

Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
por: Liu, Xinyi, et al.
Publicado: (2023)

Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Role of fiscal and monetary policies for economic recovery in China
por: Wang, Yunxian, et al.
Publicado: (2023)

Association between social determinants of health and direct economic burden on middle-aged and elderly individuals living with diabetes in China
por: Guo, Jianwei, et al.
Publicado: (2021)

Direct economic burden attributable to age-related diseases in China: An econometric modelling study
por: Ye, Xin, et al.
Publicado: (2023)

Study on the Factors Associated with Postpartum Visits in Rural China
por: You, Hua, et al.
Publicado: (2013)

Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Economic Burden for Lung Cancer Survivors in Urban China
por: Zhang, Xin, et al.
Publicado: (2017)

Exacerbation of financial burden of insulin and overall glucose‐lowing medications among uninsured population with diabetes
por: Lin, Yilu, et al.
Publicado: (2023)

Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

The economic burden of dementia in China, 1990–2030: implications for health policy
por: Xu, Junfang, et al.
Publicado: (2017)

Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China
por: Lu, Jingjing, et al.
Publicado: (2013)

Economic burden of irritable bowel syndrome in China
por: Zhang, Fang, et al.
Publicado: (2016)

Patient and economic burdens of postherpetic neuralgia in China
por: Yu, Sheng-Yuan, et al.
Publicado: (2019)

Economic Burden of Major Diseases in China in 2013
por: Song, Xianyan, et al.
Publicado: (2021)

Economic Burden of Diabetes in Urban Indians
por: Chandra, Pablo, et al.
Publicado: (2014)

Economic burden of diabetes in Brazil in 2014
por: Bahia, Luciana Ribeiro, et al.
Publicado: (2019)

The economic burden of mental disorders in China, 2005–2013: implications for health policy
por: Xu, Junfang, et al.
Publicado: (2016)

Economic burden of smoking-attributable diseases in China: A systematic review
por: Shi, Lili, et al.
Publicado: (2020)

Comparing the Economic Burden of Type 2 Diabetes Mellitus Patients with and without Medical Insurance: A Cross-Sectional Study in China
por: Yang, Chao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9nc7ffifil4frapp0mahv5sh2e